
Results
2
2 companies
MedinCell
Market Cap: €879.8m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€24.50
7D
1.7%
1Y
40.1%
DBV Technologies
Market Cap: €760.5m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.57
7D
4.9%
1Y
47.0%